Back to Search
Start Over
Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells
- Source :
- Oncology Letters
- Publication Year :
- 2017
- Publisher :
- Spandidos Publications, 2017.
-
Abstract
- Cantharidin (CTD) is a natural toxin in beetles of the Mylabris genus (blister beetle), which has been revealed to induce cell death in various types of human cancer cells. However, to the best of our knowledge, no previous studies have investigated the effect of CTD on the expression of genes and their associated signaling pathways in human bladder carcinoma cells. In the present study, CTD-induced cell morphological changes and apoptosis were observed using phase-contrast microscopy and the terminal deoxynucleotidyl transferase dUTP nick end labeling assay, respectively, in TSGH-8301 human bladder carcinoma cells. In addition, a complementary DNA microarray analysis demonstrated that CTD treatment led to a >2-fold upregulation of 269 genes. For example, the DNA damage-associated gene DNA-damage-inducible transcript 3 had a 4.75-fold upregulation. Furthermore, another 286 genes were >2-fold downregulated in response to CTD treatment. Matrix-remodeling associated 5, which is associated with cell migration and invasion, was downregulated 7.98-fold.
- Subjects :
- 0301 basic medicine
Cancer Research
Programmed cell death
TSGH-8301 cells
Cell
Biology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Downregulation and upregulation
medicine
Cantharidin
apoptosis
in vitro
Articles
Cell cycle
Molecular biology
030104 developmental biology
medicine.anatomical_structure
Oncology
Terminal deoxynucleotidyl transferase
chemistry
Apoptosis
030220 oncology & carcinogenesis
CTD
cantharidin
Subjects
Details
- ISSN :
- 17921082 and 17921074
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Oncology Letters
- Accession number :
- edsair.doi.dedup.....4ce4721220903c5f3729fede2c0ae104
- Full Text :
- https://doi.org/10.3892/ol.2017.6168